Next Article in Journal
Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment
Next Article in Special Issue
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
Previous Article in Journal
Dissolution Enhancement in Cocoa Extract, Combining Hydrophilic Polymers through Hot-Melt Extrusion
Previous Article in Special Issue
Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations
 
 
Review

Article Versions Notes

Pharmaceutics 2018, 10(3), 136; https://doi.org/10.3390/pharmaceutics10030136
Action Date Notes Link
article xml file uploaded 22 August 2018 08:45 CEST Original file -
article xml uploaded. 22 August 2018 08:45 CEST Update https://www.mdpi.com/1999-4923/10/3/136/xml
article pdf uploaded. 22 August 2018 08:45 CEST Version of Record https://www.mdpi.com/1999-4923/10/3/136/pdf
article html file updated 22 August 2018 08:46 CEST Original file -
article html file updated 31 March 2019 10:34 CEST Update -
article html file updated 15 April 2019 09:41 CEST Update -
article html file updated 29 April 2019 14:14 CEST Update -
article html file updated 6 October 2019 22:32 CEST Update -
article html file updated 10 February 2020 07:01 CET Update -
article html file updated 17 July 2022 01:20 CEST Update https://www.mdpi.com/1999-4923/10/3/136/html
Back to TopTop